An 'alarm signal' has been designed by researchers for the immune system which offers an "invaluable" early warning of recurring cancer.
Scientists believe that the new discovery will help in catching recurring cancers before they take hold and help increase patients' survival chances as successfully treated cancer often returns years later, the Independent reported.
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive results.
Advertisement
The team has also found that rousing dormant cancers could weaken them and ultimately lead to their destruction by the body defenses.
The alarm would help doctors detect early signs of the disease and give them a valuable head start, allowing them to attack a tumor before it begins to spread.
The findings are reported in the journal Nature Medicine.
Source: ANI
The findings are reported in the journal Nature Medicine.
Source: ANI
Carcinoid Tumors
Carcinoid tumors is a benign tumor that results in carcinoid syndrome. Only 8 to 10% of all carcinoid tumors are associated with the carcinoid syndrome.
Advertisement
 Brain TumorBrain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
